ArticleJournal of cancer research and clinical oncology2024

Targeting BMAL1 reverses drug resistance of acute myeloid leukemia cells and promotes ferroptosis through HMGB1-GPX4 signaling pathway.

Hong Zheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.